Valeant Pharma (VRX) says ex-CEO Pearson is still consulting in 'limited' capacity - Conf. call
Tweet
Share
E-mail
Valeant Pharma (NYSE: VRX) says ex-CEO Mike Pearson is still consulting in 'limited' capacity, according to the company's conference call on Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Buy this stock as upcoming Investor Day is an important catalyst: Mizuho
- Goldman lists 7 reasons why you should own this AI memory stock
- Current dip in this stock "creates enhanced buying opportunity": Citi
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
